Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

26.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.4K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

497
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
497
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

530
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
530
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

3.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
3.1K
Translation01:31

Translation

16.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
16.7K
Translation01:31

Translation

152.4K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
152.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-induced osteomalacia: a 2026 update.

Minerva medica·2026
Same author

Exploring the dynamics of FGF23 in patients with Hereditary Hemochromatosis type I following iron depletive treatment: a pilot study.

Journal of endocrinological investigation·2026
Same author

Magnesium as an endocrine modulator: physiological roles, clinical evidence, and therapeutic perspectives.

European journal of endocrinology·2026
Same author

Long-term treatment with denosumab in patients with celiac disease and osteoporosis at high risk of fracture: a retrospective study.

Internal and emergency medicine·2026
Same author

Burosumab treatment for children younger than 12 months with X-linked hypophosphataemia.

The lancet. Diabetes & endocrinology·2026
Same author

ADAR2 induces the differentiation of osteosarcoma cells by editing activity on IGFBP7: new implications for therapy.

Bone research·2026

Related Experiment Video

Updated: Nov 10, 2025

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.2K

FGF23 functions and disease.

Cristiana Cipriani1, Salvatore Minisola2, Luciano Colangelo2

  • 1Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy - cristiana.cipriani@gmail.com.

Minerva Endocrinology
|April 1, 2021
PubMed
Summary
This summary is machine-generated.

Fibroblast growth factor 23 (FGF23) regulates phosphate metabolism and interacts with vitamin D and parathyroid hormone. Emerging research expands understanding of FGF23

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.2K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

958

Related Experiment Videos

Last Updated: Nov 10, 2025

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.2K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.2K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

958

Area of Science:

  • Endocrinology
  • Metabolic pathways
  • Renal physiology

Background:

  • Fibroblast growth factor 23 (FGF23) is a key regulator of phosphate homeostasis.
  • Its intricate interactions with vitamin D and parathyroid hormone are crucial in human physiology and disease.
  • Recent research explores FGF23's broader systemic effects beyond the kidneys and bone.

Purpose of the Study:

  • To summarize the current understanding of FGF23's role in phosphate metabolism.
  • To highlight recent advancements in comprehending FGF23's extra-renal actions and pathway interactions.
  • To underscore the clinical implications of new FGF23 research for patient management.

Main Methods:

  • Literature review of recent studies on FGF23.
  • Analysis of FGF23's impact on renal phosphate transport.
  • Investigation of FGF23's interplay with other metabolic pathways and hormones.

Main Results:

  • FGF23 primarily acts on renal proximal tubules to control phosphate excretion.
  • Complex interactions between FGF23, vitamin D, and parathyroid hormone are central to mineral metabolism.
  • New evidence reveals FGF23's influence on various organs and metabolic systems.

Conclusions:

  • Updated knowledge of FGF23 mechanisms aids in clinical evaluation and management of related disorders.
  • Novel therapies targeting FGF23 pathways offer promising applications for FGF23-related conditions.
  • Continued research is vital for fully elucidating FGF23's complex physiological and pathological roles.